EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis and Biological Evaluation of α-Synuclein Proteolysis-Targeting Chimeras

Tianzhi Wen, Jian Chen, Wenqian Zhang, Jiyan Pang

Molecules · 2023

DOI: 10.3390/molecules28114458 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Tianzhi Wen und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Sun Yat-sen University, Guangzhou 510006, China. Hauptthemen laut MEDLINE: alpha-Synuclein, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

α-Synuclein aggregation under pathological conditions is one of the causes of related neurodegenerative diseases. PROTACs (proteolysis targeting chimeras) are bifunctional small molecules that induce a post-translational erasure of proteins via the ubiquitination of target proteins by E3 ubiquitin ligase and subsequent proteasomal degradation. However, few research studies have been conducted for targeted protein degradation of α-synuclein aggregates. In this article, we have designed and synthesized a series of small-molecule degraders 1–9 based on a known α-synuclein aggregation inhibitor sery384. In silico docking studies of sery384 with α-synuclein aggregates were accomplished to ensure that the compounds bound to α-synuclein aggregates specifically. The protein level of α-synuclein aggregates was determined to evaluate the degradation efficiency of PROTAC molecules on α-synuclein aggregates in vitro. The results show that compound 5 had the most significant degradation effect, with DC50 of 5.049 μM, and could induce the degradation of α-synuclein aggregates in a time- and dose-dependent manner in vitro. Furthermore, compound 5 could inhibit the elevation of the ROS level caused by overexpression and aggregation of α-synuclein and protect H293T cells from α-synuclein toxicity. Conclusively, our results provide a new class of small-molecule degraders and an experimental basis for the treatment of α-synuclein related neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinUbiquitin-Protein LigasesProteolysisUbiquitination

Stichwörter der Autor:innen

PROTAC (proteolysis-targeting chimera)protein aggregatesα-synuclein

Substanzen

alpha-SynucleinUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • School of Chemistry, Sun Yat-sen University, Guangzhou 510006, China.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Wen, T., Chen, J., Zhang, W., & Pang, J. (2023). Design, Synthesis and Biological Evaluation of α-Synuclein Proteolysis-Targeting Chimeras. Molecules. https://doi.org/10.3390/molecules28114458

Vancouver

Wen T, Chen J, Zhang W, Pang J. Design, Synthesis and Biological Evaluation of α-Synuclein Proteolysis-Targeting Chimeras. Molecules. 2023. doi:10.3390/molecules28114458

BibTeX
@article{Wen2023,
  author = {Wen, Tianzhi and Chen, Jian and Zhang, Wenqian and Pang, Jiyan},
  title = {Design, Synthesis and Biological Evaluation of α-Synuclein Proteolysis-Targeting Chimeras},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28114458}
}
Kostenlos starten →